This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure is particularly valuable in the development of kinase inhibitors, which are crucial in targeting various types of cancers. The presence of the pyrrolo[2,3-d]pyrimidine moiety enhances its ability to interact with ATP-binding sites of kinases, making it a promising candidate for drug discovery. Additionally, the compound's unique stereochemistry and functional groups allow for further modifications, enabling researchers to optimize its pharmacokinetic and pharmacodynamic properties. Its application extends to preclinical studies, where it is used to evaluate efficacy and safety profiles in therapeutic development.